Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
ACADIA Pharmaceuticals Inc. (ACAD) had Stock-Based Compensation of $14.70M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$268.06M |
|
$3.64M |
|
$24.79M |
|
$243.27M |
|
$272.68M |
|
$-4.62M |
|
$8.60M |
|
$3.98M |
|
$3.98M |
|
$3.64M |
|
$3.64M |
|
$3.64M |
|
$3.64M |
|
$-4.62M |
|
$-2.08M |
|
170.52M |
|
172.71M |
|
$0.02 |
|
$0.02 |
|
| Balance Sheet Financials | |
$1.10B |
|
$14.65M |
|
$509.21M |
|
$1.61B |
|
$305.52M |
|
-- |
|
$51.64M |
|
$357.16M |
|
$1.25B |
|
$1.14B |
|
$1.25B |
|
171.09M |
|
| Cash Flow Statement Financials | |
$33.98M |
|
$66.28M |
|
$4.23M |
|
$185.54M |
|
$290.06M |
|
$104.52M |
|
|
Stock-Based Compensation |
$14.70M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.59 |
|
-- |
|
-- |
|
-- |
|
-- |
|
90.75% |
|
-1.72% |
|
-1.72% |
|
-- |
|
1.49% |
|
1.36% |
|
$28.77M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.79 |
|
1.81 |
|
49.82 |
|
0.29% |
|
0.32% |
|
0.23% |
|
0.29% |
|
$7.29 |
|
$0.17 |
|
$0.20 |
|